Gregory`s Pediatric Anesthesia Chapter 20

advertisement
Gregory’s Pediatric Anesthesia
Chapter 20 - References
1. Locatelli A, Roncaglia N, Andreoti C et al. Factors affecting survival in infants
weighing 750 g or less. Eur J Obstet Gynecol Reprod Biol 2005; 123: 52–55.
2. Usher RH, Allen AC, McLean FH. Risk of respiratory distress syndrome related to
gestational age, route of delivery and maternal diabetes. Am J Obstet Gynecol 1971;
111: 826–32.
3. Bland RD, McMillan DO, Bressack MA, Dong L. Clearance of liquid from lungs of
newborn rabbits. J Appl Physiol 1980; 49: 171–7.
3. Karlberg P. The adaptive changes in the immediate postnatal period with particular
reference to respiration. J Pediatr 1960; 56: 585–604.
4. Lou HC, Lassen NA, Friis-Hansen B. Low cerebral blood flow in hypotensive perinatal
distress. Acta Neurol Scand 1977; 56: 343–52.
5. Lou HC, Lassen NA, Friis-Hansen B. Impaired autoregulation of cerebral blood flow in
the distressed newborn infant. J Pediatr 1979; 94: 118–21.
6. Sola A, Gregory GA. Delivery room emergencies and newborn resuscitation. In:
Rudolph CR, Rudolph AM, Hostetter M et al. (eds) Rudolph’s Pediatrics, 21st edn. New
York: McGraw-Hill, 2003, pp.97–103.
7. Finer NN, Carlo W, Walsh MC et al. Early CPAP versus surfactant in extremely
preterm infants. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD
Neonatal Research Network. N Engl J Med 2010; 362: 1970–9.
8. Morley CJ, Davis PG, Doyle LW et al. Nasal CPAP or intubation at birth for very
preterm infants. N Engl J Med 2008; 358: 700–8.
9. Jankov R. Hypercapnea and the neonate. Acta Paediatr 2008; 97: 1502–9.
10. Lubchenco LD, Horner FA, Reed LH et al. Sequelae of premature birth: evaluation of
premature infants of low birth weights at ten years of age. Am J Dis Child 1963; 106:
101–15.
11. Meyers RE. Focal patterns of perinatal brain damage and their conditions of
occurrence in primates. Adv Neurol 1975; 10: 2–10.
12. Hazan J, Maag U, Chessex P. Association between hypothermia and mortality rate
of premature infants – revisited. Am J Obstet Gynecol 1991; 164: 111–12.
13. Hey EN. The relation between environmental temperature and oxygen consumption
in the newborn baby. J Physiol 1969; 200: 589–603.
14. Brück K. Which environmental temperature does the premature infant prefer?
Pediatrics 1968; 41: 1027–30.
15. Knobel RB, Holditch-Davis D, Schwartz TA, Wimmer JE. Extremely low birth weight
infants lack vasomotor response in relationship to cold body temperatures at birth. J
Perinatol 2009; 29: 814–21.
16. Silverman WA, Sinclair JC. Temperature regulation in the newborn infant. N Engl J
Med 1966; 279: 146–8.
17. Hardman MJ, Hey EN, Hull D. Energy sources of thermogenesis in the newborn
rabbit. J Physiol 1969; 201: 84P–85P.
18. Baumgart S, Engle WD, Fox WW, Polen RA. Radiant warmer power and body size
as determinants of insensible water loss in the critically ill neonate. Pediatr Res 1981;
15: 1495–9.
19. Baumgart S. Reduction of oxygen consumption, insensible water loss, and radiant
heat demand with use of a plastic blanket for low-birth-weight infants under radiant
warmers. Pediatrics 1984; 74: 1022–8.
20. Buisson P, Bach V, Elabbassi EB et al. Assessment of the efficiency of warming
devices during neonatal surgery. Eur J Appl Physiol 2004; 92: 694–7.
21. McCall EM, Alderice F, Halliday HL et al. Interventions to prevent hypothermia at
birth in preterm and/or low birth-weight infants (review). Cochrane Database Syst Rev
2010; 17: CD004210.
22. D' Alessio JG, Ramanathan J. Effects of maternal anesthesia in the neonate. Semin
Perinatol 1998; 22: 350–62.
23. Jobe AH. Lung maturation: the survival miracle of very low birth weight infants.
Pediatr Neonatol 2010; 51: 7–13.
24. Jobe A, lkegami M. Surfactant for the treatment of respiratory distress syndrome. Am
Rev Respir Dis 1987; 136: 1256–75.
25. Phibbs RH, Ballard RA, Clements JA et al. Initial clinical trial of EXOSURF, a proteinfree synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane
disease. Pediatrics 1991; 88: 1–9.
26. Eichenwald EC, Stark AR. Management and outcomes of very low birth weight. N
Engl J Med 2008; 358: 1700–11.
27. Walsh MC, Hibbs AM, Martin CR et al. Two-year neurodevelopmental outcomes of
ventilated preterm infants treated with inhaled nitric oxide. J Pediatr 2010; 156: 556–61.
28. Zanardo V, Vedovato S, Cosmi E et al. Preterm premature rupture of membranes,
chorioamnion inflammatory scores and neonatal respiratory outcomes. Br J Obstet
Gynaecol 2010; 117: 94–8.
29. Tyson JE, Parikh NA, Langer J et al. Intensive care for extreme prematurity – moving
beyond gestational age. N Engl J Med 2008; 358: 1672–81.
30. Oishi M, Nishida H, Sasak T. Japanese experience with micropremies weighing less
than 600 grams born between 1984 to 1993. Pediatrics 1997; 99: E7.
31. Northway WH Jr, Rosen RC, Porter DY. Pulmonary disease following respirator
therapy of hyaline membrane disease: bronchopulmonary dysplasia. N Engl J Med
1967; 276: 357–68.
32. Gonzalez A, Sosenko IRS, Chandar J et al. Influence of infection on patent ductus
arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J
Pediatr 1996; 128: 470–8.
33. Rojas MA, Gonzalez A, Bancalari E et al. Changing trends in the epidemiology and
pathogenesis of neonatal chronic lung disease. J Pediatr 1995; 126: 605–10.
34. Bancalri E, Claure N, Sosenko IRS. Bronchopulmonary dysplasia: changes in
pathogenesis, epidemiology and definition. Semin Neonatol 2003; 8: 63–71.
35. Jobe AH. An unknown: lung growth and development after very preterm birth. Am J
Resp Crit Care Med 2002; 166: 1529–30.
36. Jacob SV, Lands LC, Coates AL et al. Exercise ability in survivors of severe
bronchopulmonary dysplasia. Am J Respir Crit Care Med 1997; 155: 1925–9.
37. Mitchell SH, Teague WG. Reduced gas transfer at rest and during exercise in
school-age survivors of bronchopulmonary dysplasia. Am J Crit Care Med 1998; 157:
1406–12.
38. Miller MJ, Martin RJ. Apnea of prematurity. Clin Perinatol 1992; 19: 789–808.
39. Engoren M, Courtney SE, Habib RM. Effect of weight and age on respiratory
complexity in premature neonates. J Appl Physiol 2009; 106: 766–73.
40. Walther-Larsen S, Rasmusen LS. The former preterm infant and risk of postoperative apnoea: recommendations for management. Acta Anaesthesiol Scand 2006;
50: 888–93.
41. Henderson-Smart DJ, Steer PA. Prophylactic caffeine to prevent postoperative
apnea following general anesthesia in preterm infants (review). Cochrane Database Syst
Rev 2010; 20(1): CD000273.
42. Bjorklund U, lngimarsson J, Curstedt T et al. Manual ventilation with a few large
breaths at birth compromises the therapeutic effect of subsequent surfactant
replacement in immature lambs. Pediatr Res 1997; 42: 348–55.
43. Hillman NH, Kallapur SG, Pillow JJ et al. Airway injury from initiating ventilation in
preterm sheep. Pediatr Res 2010; 67: 60–5.
44. Clyman RI. Patent ductus arteriosus in the preterm. In: Taeusch HW, Ballard R,
Gleason C (eds) Avery's Diseases of the Newborn, 6th edn. Philadelphia: ElsevierSaunders, 2000.
45. Lim MK, Hanretty K, Houston AB et al. Intermittent ductal patency in healthy
newborn infants: demonstration by color Doppler flow mapping. Arch Dis Child 1992; 67:
1217–18.
46. Kitterman JA, Edmunds LH Jr, Gregory GA et al. Patent ductus arteriosus in
premature infants: incidence, relation to pulmonary disease and management. N Engl J
Med 1972; 287: 473–7.
47. McGrath RC, McGuinness GA, Way GC et al. The silent ductus arteriosus. J Pediatr
1978; 93: 110–13.
48. Radtke WA. Current therapy of the patent ductus arteriosus. Curr Opin Cardiol 1998;
13: 59–65.
49. Stevenson JG. Fluid administration in the association of patent ductus arteriosus
complicating respiratory distress syndrome. J Pediatr 1977; 90: 257–61.
50. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in
premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976; 295: 530–
3.
51. Merritt TA, DiSessa TG, Feldman BH et al. Closure of the patent ductus arteriosus
with ligation and indomethacin: a consecutive experience. J Pediatr 1978; 93: 639–46.
52. Hamrick SG, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics
2010; 125: 1020–30.
53. Kitterman JA. Effects of intestinal ischemia in necrotizing enterocolitis in the newborn
infant. In: Moore TD (ed) Report of the Sixty-Eighth Ross Conference on Pediatric
Research. Columbus, OH: Ross Laboratories Press, 1975, pp.38–45.
54. Spector SA, Ticknor W, Grossman M. Study of the usefulness of clinical and
hematologic findings in the diagnosis of neonatal bacterial infections. Clin Pediatr 1981;
20: 385–92.
55. Avery GB. Neonatology. 4th edn. Philadelphia: JB Lippincott, 1994.
56. Albanese CT, Rowe MI. Necrotizing enterocolitis. Semin Pediatr Surg 1995; 4: 200–
6.
57. Lin PW, Stoli BJ. Necrotizing enterocolitis. Lancet 2006; 368: 1271–83.
58. Santulli TV, Schullinger JN, Heird WC et al. Acute necrotizing enterocolitis in infancy:
a review of 64 cases. Pediatrics 1975; 55: 376–87.
59. Kliegman RM, Walker WA, Yolken RH. Necrotizing enterocolitis: research agenda for
a disease of unknown etiology and pathogenesis. Pediatr Res 1993; 34: 701–8.
60. Arnold M, Moore SW, Sidler D. Long-term outcome of surgically managed
necrotizing enterocolitis in a developing country. Pediatr Surg Int 2010; 26: 355–60.
61. Thompson AM, Bizzarro MJ. Necrotizing enterocolitis in newborns: pathogenesis,
prevention, management. Drugs 2008; 68: 1227–38.
62. Bell EF, Strauss RG, Widness JA et al. Randomized trial of liberal restrictive
guidelines for red blood cell transfusion in preterm infants. Pediatrics 2005; 115: 1685–
91.
63. Kirpalani H, Whyte RK, Andersen C et al. The premature infants in need of
transfusion (PINT) study: a randomized controlled trial of a restrictive (low) versus liberal
(high) transfusion threshold for extremely low birth weight infants. J Pediatr 2006; 149:
301–7.
64. Phibbs RH, Shannon KM, Mentzer WC. Potential for treatment of anemia of
prematurity with recombinant human erythropoietin: preliminary results. Acta Haematol
1992; 87 Suppl 1: 28–33.
65. Ibrahim HM, Jeroudi MA, Baier RJ et al. Aggressive early total parental nutrition in
low birth-weight infants. J Perinatol 2004; 24: 482–6.
66. Clarke P, Mitchell SJ, Wynn R et al. Vitamin K prophylaxis for preterm infants: a
randomized, controlled trial of 3 regimens. Pediatrics 2006; 118: e1657–66.
67. Jain A, Agerwal R, Sankar MJ et al. Hypocalcemia in the newborn. Indian J Pediatr
2008; 75: 165–9.
68. Nelson N, Finnstrom O, Larsson L. Plasma ionized calcium, phosphate and
magnesium in preterm and small for gestational age infants. Acta Paediatr Scand 1989;
78: 351–7.
69. Van den Akker CHP, Vlaardingerbroek H, van Goudoever JB. Nutritional support for
extremely low-birth weight infants: abandoning catabolism in the neonatal intensive care
unit. Curr Opin Clin Nut Metab Care 2010; 13: 327–35.
70. LeBlanc MH, Huang M, Vig V et al. Glucose affects the severity of hypoxic-ischemic
brain injury in newborn pigs. Stroke 1993; 24: 1055–62.
71. Sheldon RA, Partridge JC, Ferriero DM. Postischemic hyperglycemia is not
protective to the neonatal rat brain. Pediatr Res 1992; 32: 489–93.
72. Alverson DC. The physiologic impact of anemia in the neonate. Clin Perinatol 1995;
22: 609–25.
73. Watchko JF. Hyperbilirubinemia and bilirubin toxicity in the late preterm infant. Clin
Perinatol 2006; 33: 839–52.
74. Watchko JF. Identification of neonates at risk for hazardous hyperbilirubinemia:
emerging clinical insights. Pediatr Clin North Am 2009; 56: 671–87.
75. Palmer EA, Flynn JT, Hardy RJ et al. Incidence and early course of retinopathy of
prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Ophthalmology 1991; 98: 1628–40.
76. Gole GA, Ellis AL, Katz X et al. The international classification of retinopathy of
prematurity revisited. International Committee for the Classification of Retinopathy of
Prematurity. Arch Opthamol 2005; 123: 991–9.
77 Hunter DG, Mukai S. Retinopathy of prematurity: pathogenesis, diagnosis, and
treatment. Int Ophthalmol Clin 1992; 32: 163–84.
78. Chen ML, Guo L, Smith LEH et al. High or low oxygen saturation and severe
retinopathy of prematurity: a meta-analysis. Pediatrics 2010; 125: e1483–92.
79. Dammann O. Inflammation and retinopathy of prematurity. Acta Paediatr 2010; 99:
975–7.
80. Saugstad OD. Oxidative stress in the newborn – a 30-year perspective. Biol Neonate
2005; 88: 228–36.
81. Connor KM, Loqvist C, Aderman CM et al. Increased dietary intake of omega-3polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 2007;
13: 868–73.
82. Finer NN, Peters KL, Hayek Z, Mekrel CL. Vitamin E and necrotizing enterocolitis.
Pediatrics 1984; 73: 387–93.
83. Johnson L, Bowen FW, Abbasi S et al. Relationship of prolonged pharmacological
serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants
with birth weight 1,500 gram or less. Pediatrics 1985; 75: 619–38.
84. Kingham JD. Acute retrolental fibroplasia. Arch Ophthalmol 1997; 95: 39–47.
85. Good WW. Final results of the early treatment for retinopathy of prematurity
(ETROP) randomized trial. Trans Am Ophthalmol Soc 2004; 102: 233–48.
86. Wasunna A, Whitelaw AG. Pulse oximetry in preterm infants. Arch Dis Child 1987;
62: 957–8.
87. Aoyama K, Kondou Y, Suzuki Y et al. Anesthesia protocols for early vitrectomy in
former preterm infants diagnosed with aggressive posterior retinopathy of prematurity. J
Anesth 2010; 24(4): 633–8.
88. Del Toro J, Louis PT, Goddard-Finegold J. Cerebrovascular regulation and neonatal
brain injury. Pediatr Neurol 1991; 7: 3–12.
89. Pryds O, Greisen G, Skov LL, Friis-Hansen B. Carbon dioxide-related changes in
cerebral blood volume and cerebral blood flow in mechanically ventilated preterm
neonates: comparison of near infrared spectrophotometry and 133Xenon clearance.
Pediatr Res 1990; 27: 445–9.
90. Lou HC, Lassen NA, Friis-Hansen B. Is arterial hypertension crucial for the
development of cerebral haemorrhage in premature infants? Lancet 1979; 1(8128):
1215–17.
91. Perkin RM, Levin DL, Clark R. (1980) Serum salicylate levels and right–to left ductus
shunts in newborn infants with persistent pulmonary hypertension. J Pediatr 96: 721–26.
92. Van Mater LJ, Alred EN, Pagano M et al. Persistent pulmonary hypertension of the
newborn and smoking and aspirin and nonsteroidal anti-inflammatory drug consumption
during pregnancy. Pediatrics 1996; 97: 658–63.
93. Sullivan WG. Respiratory distress following cleft lip repair: the role of obligatory nasal
breathing in the infant. Ann Plastic Surg 1988; 20: 590–2.
94. Baht RY, Leipala JA, Rafferty GF et al. Effects of posture on oxygenation, lung
volume, and respiratory mechanics in premature infants studied before discharge.
Pediatrics 2003; 112: 29–32.
95. Peabody JL, Gregory GA, Willis MM et al. Failure of conventional monitoring to
detect apnea resulting from hypoxemia. Birth Defects Orig Artic Ser 1979; 15: 274–84.
96. Pape KE, Armstrong DL, Fitzhardinge PM. Central nervous system pathology
associated with mask ventilation in very low birth weight infants: a new etiology –
intracerebellar hemorrhage. Pediatrics 1976; 58: 473–83.
97. Gregory GA. Respiratory care of the child. Crit Care Med 1980; 8: 582–7.
98. Wilkinson AR, Phibbs RH, Gregory GA. Continuous in vivo oxygen saturation in
newborn infants with pulmonary disease: a new fiberoptic catheter oximeter. Crit Care
Med 1979; 7: 232–6.
99. Dempsey EM, Barrington KJ. Evaluation and treatment of hypotension in the preterm
infant. Clin Perinatol 2009; 36: 75–85.
100. Barrington KJ. Hypotension and shock in the preterm infant. Semin Fetal Neonatal
Med 2008; 13: 16–23.
101. Wu PY, Hodgman JE. Insensible water loss in preterm infants: changes with
postnatal development and non-ionizing radiant energy. Pediatrics 1974; 54: 704–12.
102. Sola A, Gregory GA. Colloid oncotic pressure of normal newborns and preterm
infants. Crit Care Med 1981; 9: 568–72.
103. Bhat R, Javed S, Malais L, Vidysagar D. Critical care problems in neonates: colloid
osmotic pressure in healthy and sick neonates. Crit Care Med 1981; 9: 563–7.
104. Pichler E, Pichler L. The neonatal coagulation system and the vitamin K deficiency
bleeding – a mini review. Wein Med Wochenschr 2008; 158: 385–95.
105. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the
neonate and young infant. Am J Pediatr Hem Oncol 1990; 12: 95–104.
106. Male C, Johnston M, Sparling C et al. The influence of developmental haemostasis
on the laboratory diagnosis and management of haemostatic disorders during infancy
and childhood. Clin Lab Med 1999; 19: 39–69.
107. Hathaway WE. The bleeding newborn. Semin Hematol 1975; 12: 175–88.
108. Mallick MS, Jado AM, Al-Bassam AR. Surgical procedures performed in the
neonatal intensive care unit on critically ill neonates: feasibility and safety. Ann Saudi
Med 2008; 28: 105–8.
109. Anand KJS, Sippell WG, Aynsley-Green A. Randomized trial of fentanyl
anaesthesia in preterm babies undergoing surgery: effects on the stress response.
Lancet 1987; 1(8524): 62–6.
110. Robinson SR, Gregory GA. Fentanyl–air oxygen anesthesia for ligation of patent
ductus arteriosus in preterm infants. Anesth Analg 1981; 60: 331–4.
111. LeDez KM, Lerman J. The minimum alveolar concentration (MAC) of isoflurane in
neonates. Anesthesiology 1987; 67: 301–7.
112. Greisen G. Autoregulation of cerebral blood flow in newborn babies. Early Hum
Develop 2005; 81: 423–8.
113. Gregory GA. The baroresponses of preterm infants during halothane anesthesia.
Can Anaesth Soc J 1982; 29: 105–7.
114. Duncan PG, Gregory GA, Wade JG. The effect of nitrous oxide on the baroreceptor
response of newborn and adult rabbits. Can Anaesth Soc J 1981; 28: 339–41.
115. Murat I, Levron le, Berg A, Saint-Maurice C. Effect of fentanyl on baroreceptor
reflex control of heart rate in newborn infants. Anesthesiology 1988; 68: 717–22.
116. Vidyasagar D, Raju TNK, Chiang I. Clinical significance of monitoring anterior
fontanel pressure in sick neonates and children. Pediatrics 1978; 62: 996–9.
117. Lerman J, Robinson S, Willis MM, Gregory GA. Anesthetic requirements for
halothane in young children 0–1 month and 1–6 months of age. Anesthesiology 1983;
59: 421–4.
118. Friesen RH, Henry DB. Cardiovascular changes in preterm neonates receiving
isoflurane, halothane, fentanyl, and ketamine. Anesthesiology 1986; 64: 238–42.
119. Gootman PM, Buckley NM, Gootman N et al. Integrated cardiovascular responses
to combined somatic afferent stimulation in newborn piglets. Biol Neonate 1978; 34:
187–98.
120. Koehntop DE, Rodman JH, Brundage DM et al. Pharmacokinetics of fentanyl in
neonates. Anesth Analg 1986; 65: 227–32.
121. Versmold HT, Kitterman JA, Phibbs RH et al. Aortic blood pressure during the first
12 hours of life in infants with birth weight 610–4200 grams. Pediatrics 1981; 67: 607–
13.
122. Tanaka A, Rugolo LM, Miranda AF, Trindade CE. Fractional sodium excretion,
urinary osmolality and specific gravity in preterm infants fed with fortified donor human
milk. J Pediatr (Rio J) 2006; 82: 335–40.
123. Steward DJ. Preterm infants are more prone to complications following minor
surgery than are term infants. Anesthesiology 1982; 56: 304–6.
124. Liu LMP, Cote CJ, Goudsouzian NG et al. Life-threatening apnea in infants
recovering from anesthesia. Anesthesiology 1983; 59: 506–10.
125. Walther-Larsen S, Rasmussen LS. The former preterm infant and risk of
postoperative apnoea: recommendations for management. Acta Anaesthesiol Scand
2006; 50: 888–93.
126. Wear R, Robinson S, Gregory GA. The effect of halothane on the baroresponse of
adult and baby rabbits. Anesthesiology 1982; 56: 188–91.
127. Henderson-Smart D, Pettigrew AG, Campbell DJ. Clinical apnea and brain stem
neural function in preterm infants. N Engl J Med 1983; 308: 353–7.
128. Allen AS, Cox CS, White N et al. Postoperative respiratory complications in expremature infants after inguinal herniorrhaphy. J Pediatr Surg 1998; 33: 1095–8.
129. Melone JH, Schwartz MZ, Tyson KR et al. Outpatient inguinal herniorrhaphy in
premature infants: is it safe? J Pediatr Surg 1992; 27: 203–7.
130. Welborn LG, Hannallah RS, Luban NL et al. Anemia and postoperative apnea in
former preterm infants. Anesthesiology 1991; 74: 1003–6.
131. Welborn LG, Rice U, Hannallah RS et al. Postoperative apnea in former preterm
infants: prospective comparison of spinal and general anesthesia. Anesthesiology 1990;
72: 838–42.
132. Veverka TJ, Henry DN, Milroy MJ et al. Spinal anesthesia reduces the hazard of
apnea in high-risk infants. Am J Surg 1991; 57: 531–4.
133. Cox RG, Goresky GV. Life-threatening apnea following spinal anesthesia in former
premature infants. Anesthesiology 1990; 73: 345–7.
134. Desparmet JF. Total spinal anesthesia after caudal anesthesia in an infant. Anesth
Analg 1990; 70: 665–7.
135. Kunst G, Linderkamp O, Holle R et al. The proportion of high risk preterm infants
with postoperative apnea and bradycardia is the same after general and spinal
anesthesia. Can J Anaesth 1999; 46: 94–5.
136. Tashiro C, Matsui Y, Nakano S et al. Respiratory outcome in extremely premature
infants following ketamine anaesthesia. Can J Anaesth 1991; 38: 287–91.
137. Kurth CD, LeBard SE. Association of postoperative apnea, airway obstruction, and
hypoxemia in former premature infants. Anesthesiology 1991; 75: 22–6.
138. Welborn LG, de Soto H, Hannallah RS et al. The use of caffeine in the control of
post-anesthetic apnea in former premature infants. Anesthesiology 1988; 68: 796–8.
139. Kilpatrick SJ, Schluetter MA, Piecuch R et al. Outcome of infants born at 24–26
weeks' gestation: I. survival and cost. Obstet Gynecol 1997; 90: 803.
140. Piecuch RE, Leonard CH, Cooper BA et al. Outcome of infants born at 24–26
weeks' gestation: II. neurodevelopmental outcome. Obstet Gynecol 1997; 90: 809–14.
Download